We are monitoring the impact of COVID-19 on Europe Artificial Organs And Bionics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1581
Share on
Share on

Europe Artificial Organs and Bionics Market Research Report - Segmented By Product, Technology, Fixation Type & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 1581
Pages: 145

Europe Artificial Organs and Bionics Market Size (2021 to 2026):

In 2019, Europe was the second-largest region in the global artificial organs and bionics market. Between 2021 to 2026, the European artificial organs and bionics market is forecasted to grow at a CAGR of 8.90%. This market was worth USD 6.52 Billion in 2021 and predicted to grow USD 9.99 Billion by 2026.

The last few years have seen technological innovations in the medical bionic implant industry. Newer, safer, and more effective products contribute to the widespread adoption of medical bionics by physicians. The rising prevalence of kidney disorders, acute kidney failure, and increasing organ failure due to the aging population drive the market in this region. Rapid involvement in the field of biomedical sciences has made organ transplantation a common practice. According to estimates by the British Heart Foundation, in 2019, around 7.3 million people were living with heart and circulatory disease in the UK and healthcare costs related to heart and circulatory disease were estimated at 9.2 million thousand GBP every year. Therefore, the increasing prevalence of chronic diseases helps stimulate the demand for artificial and bionic organs.

Moreover, the evolution of bionic orthopedics, bionic eye, and the exoskeleton is driving the market growth. According to the European Heart Network, cardiovascular disease (CVD) is responsible for 4.1 million deaths each year in Europe and more than 2.1 million deaths in the European Union. Death rates from ischemic heart disease (IC) and stroke usually are higher in central and eastern Europe than in northern, southern, and western Europe. Cardiovascular disease causes 45 times the number of deaths and 12 times the loaf of disease caused by AIDS, tuberculosis, and malaria merged in Europe. Therefore, with this substantial patient population, cardiac bionics and artificial heart call are anticipated to rise during the forecast period.

However, elements such as fear of device breakdown, risk of compatibility with artificial organs, and its outcomes, among others, may affect the development of the market. These implants are also expensive, which has also been a limiting factor for the market's growth.

This research report on the Europe Artificial Organs and Bionics Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Artificial Organs
  • Bionics

By Technology:

  • Electronic Bionics
  • Mechanical Bionics

By Fixation Type:

  • Implantable
  • Externally Worn
  • Cardiac Bionics
  • Brain Bionics

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regional Analysis:

Europe is the second biggest market in terms of market share across the globe. There is a high demand from the patients for organ transplantation surgery, whereas the donors' availability to fulfill this demand is low. Due to this factor, the market is experiencing fair growth in Europe. The growth of the market in the country can be attributed to the increasing incidence of disabilities, organ failure, and organ donor shortage. The European market for artificial and bionic organs is expected to experience a phase of constant growth due to several factors affecting the health sector, such as the concentration of public spending in the health sector, mainly on research and development. Public health expenditure in the EU was recorded at USD 1,312,214 million, or around 8.1% of GDP in 2019. Europe's GDP growth rate was recorded at 2.4% in 2019, higher than the 1.9% recorded in 2018. Healthcare spending was the highest in Germany, France, and Sweden relative to their GDP, and Germany recorded the highest healthcare spending with $ 398.42 billion in 2018. In 2019, the EU region recorded health expenditure of around 9.7% of its GDP. The population growth rate in the EU-28 was slightly high, with population growth from 51,38,48,812 people in 2013 to 52,14,63,312 people in 2019. Life expectancy had improved slightly, and it was estimated at 82.8 years in 2019.

Moreover, since 2005, an escalation in the number of doctors per capita has been observed. An increase in public health expenditure as a percentage of GDP over the next decade. With many health policies of EU governments taking center stage in recent years, habits such as smoking and alcohol consumption have declined, and lifestyle-related diseases such as obesity were more prevalent among the country's least educated population.

Prominent Companies dominating the Europe Artificial Organs and Bionics Market Profiled in the Report are Orthofix International N.V., Biomet, Inc., Medtronic, Inc., Cochlear Ltd., Second Sight Medical Products, Inc., Ossur, Ekso Bionics, St. Jude Medical, Inc., Baxter International, Inc., Abiomed Inc., Asahi Kasei Medical Co., Ltd, Berlin Heart GmbH, Boston Scientific Corporation, F Hoffman-La Roche Ltd, Worldheart Corporation, Thoratec Corporation, Gambro AB, Lifenet Health, Jarvik Heart Inc.

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction      

                2.2 Research Phases                      

        2.2.1 Secondary Research            

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling     

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market               

5. Market Segmentation                      

                5.1 Product

        5.1.1 Introduction           

        5.1.2 Artificial Organs    

                        5.1.2.1 Artificial Heart

                        5.1.2.2 Artificial Kidney

                        5.1.2.3 Artificial liver

                        5.1.2.4 Artificial pancreas

                        5.1.2.5 Artificial lungs

        5.1.3 Bionics      

                        5.1.3.1 Vision bionics

                        5.1.3.2 Ear bionics

                        5.1.3.3 Orthopedic bionic

                        5.1.3.4 Cardiac Bionics

                        5.1.3.5 Brain bionics

        5.1.4  Y-o-Y Growth Analysis, By Product               

        5.1.5  Market Attractiveness Analysis, By Product             

        5.1.6  Market Share Analysis, By Product               

                5.2 Technology                

        5.2.1 Introduction           

        5.2.2 Electronic bionics 

        5.2.3 Mechanical bionics              

        5.2.4 Y-o-Y Growth Analysis, By Technology         

        5.2.5 Market Attractiveness Analysis, By Technology       

        5.2.6 Market Share Analysis, By Technology        

                5.3 Type of fixation

        5.3.1 Introduction           

        5.3.2 Implantable            

        5.3.3 Externally worn    

        5.3.4  Y-o-Y Growth Analysis, By Type of fixation

        5.3.5  Market Attractiveness Analysis, By Type of fixation              

        5.3.6  Market Share Analysis, By Type of fixation               

6. Geographical Analysis                      

                6.1 Introduction      

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Product

                        6.1.3.3 By Technology

                        6.1.3.4 By Type of fixation

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Product

                        6.1.4.3 By Technology

                        6.1.4.4 By Type of fixation

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Product

                        6.1.5.3 By Technology

                        6.1.5.4 By Type of fixation

                6.2 U.K                

                6.3 Spain     

                6.4 Germany                     

                6.5 Italy       

                6.6 France  

                6.7 Rest of Europe

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental      

               7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services

        7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                  

                 8.1 Orthofix International N.V.                  

        8.1.1 Overview

                                   8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Biomet, Inc.                

                8.3 Medtronic, Inc. 

                8.4 Cochlear Ltd.     

                8.5 Second Sight Medical Products, Inc.                 

                8.6 Ossur    

                8.7 Ekso Bionics               

                8.8 St. Jude Medical, Inc.      

                8.9 Baxter International, Inc.                      

                8.10 Abiomed Inc.   

                8.11 Asahi Kasei Medical Co., Ltd      

                8.12 Berlin Heart GmbH               

                8.13 Boston Scientific Corporation   

                8.14 F Hoffman-La Roche Ltd                     

                8.15 Worldheart Corporation                     

                8.16 Thoratec Corporation  

                8.17 Gambro AB      

                8.18 Lifenet Health 

                8.19 Jarvik Heart Inc.                     

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  2. Europe Artificial Organs Market By Region, From 2021 to 2026 ( USD Billion )
  3. Europe Bionics market Market By Region, From 2021 to 2026 ( USD Billion )
  4. Europe Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  5. Europe Electronic bionics Market By Region, From 2021 to 2026 ( USD Billion )
  6. Europe Mechanical bionics Market By Region, From 2021 to 2026 ( USD Billion )
  7. Europe Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  8. Europe Implantable Market By Region, From 2021 to 2026 ( USD Billion )
  9. Europe Externally worn Market By Region, From 2021 to 2026 ( USD Billion )
  10. U.K. Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  11. U.K. Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  12. U.K. Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  13. Germany Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  14. Germany Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  15. Germany Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  16. France Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  17. France Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  18. France Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  19. Italy Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  20. Italy Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  21. Italy Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  22. Spain Artificial Organs and Bionics Market By Product, From 2021 to 2026 ( USD Billion )
  23. Spain Artificial Organs and Bionics Market By Technology, From 2021 to 2026 ( USD Billion )
  24. Spain Artificial Organs and Bionics Market By Type of fixation, From 2021 to 2026 ( USD Billion )
  25. Europe Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  26. Europe Artificial Heart Market By Region, From 2021 to 2026 ( USD Billion )
  27. Europe Artificial Kidney Market By Region, From 2021 to 2026 ( USD Billion )
  28. Europe Artificial liver Market By Region, From 2021 to 2026 ( USD Billion )
  29. Europe Artificial pancreas Market By Region, From 2021 to 2026 ( USD Billion )
  30. Europe Artificial lungs Market By Region, From 2021 to 2026 ( USD Billion )
  31. U.K. Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  32. Germany Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  33. France Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  34. Italy Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  35. Spain Artificial Organs Market By Artificial Organs, From 2021 to 2026 ( USD Billion )
  36. Europe Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )
  37. Europe Vision bionics Market By Region, From 2021 to 2026 ( USD Billion )
  38. Europe Ear bionics Market By Region, From 2021 to 2026 ( USD Billion )
  39. Europe Orthopedic bionic Market By Region, From 2021 to 2026 ( USD Billion )
  40. Europe Cardiac Bionics Market By Region, From 2021 to 2026 ( USD Billion )
  41. Europe Brain bionics Market By Region, From 2021 to 2026 ( USD Billion )
  42. U.K. Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )
  43. Germany Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )
  44. France Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )
  45. Italy Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )
  46. Spain Bionics Market By Bionics, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample